Skip to main content
OpenTrials

Clinical trial condition

AML With FLT3 Mutation

Explore clinical trials studying AML With FLT3 Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

AML With FLT3 Mutation trial results

Active, not recruiting

A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation

NCT03182244

Conditions
AML With FLT3 Mutation, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site CN103 Beijing, China
  • Site CN108 Beijing, China
  • Site CN109 Beijing, China
  • Site CN110 Beijing, China
View all 49 locations
View Trial Details

Related conditions